PATENT CLAIM ANALYSIS

Application Number: 15756824
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
Provided are a monoclonal antibody specific for BQ323636.1, and its use for prediction of tamoxifen resistance in breast cancer patients.

Claim (Index 8):
The antibody or antibody fragment of  claim 1 , wherein the antibody or antibody fragment has a V 11  amino acid sequence of SEQ ID NO: 3.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14429657', '10591199', '13568145', '13177523', '12825057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7312520747809733
- 35 USC 102 Novelty (BERT): 0.5062911199370523
- Combined Prediction Score: 0.7087559792965812
- Mean Citation Score: 266.799774
- Max Citation Score: 274.01337
- Similarity Product: 202.8071671087825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test